Quarterly Result25 Jul 2026, 12:31 pm
Mercury Laboratories Ltd Approves Unaudited Q1 FY27 Financial Results
AI Summary
Mercury Laboratories Ltd announced that its Board of Directors, at a meeting held on July 25, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The company also submitted the Limited Review Report from its statutory auditors. The meeting commenced at 9:30 a.m. IST and concluded at 11:33 a.m. IST. The results were prepared in accordance with Indian Accounting Standards and SEBI (LODR) Regulations, 2015. The company operates in a single segment: Pharmaceuticals Products.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Limited Review Report from auditors submitted.
- Results prepared as per Indian Accounting Standards.
- Company operates in a single 'Pharmaceuticals Products' segment.
Price Impact
More from MERCURYLAB